Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K. As of such date, there were 56,296,895 shares of common stock issued and outstanding. Beneficial ownership is determined in
of this Current Report on Form 8-K, the Company’s operations consist of an (i) an artificial intelligence-enabled healthcare analytics system (the “AI Healthcar
Unregistered Sales of Equity Securities On February 17, 2026, in connection with the acquisition of certain assets pursuant to the Asset Purchase Agreement desc
of this Current Report on Form 8-K, and (ii) 12,000,000 shares of restricted common stock issued pursuant to the Asset Purchase Agreement described in Item 1.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Effective February 17, 2026, in connection with the change in
Financial Statements and Exhibits (a) Financial Statements of Businesses Acquired The acquisition described in Item 2.01 of this Current Report on Form 8-K was